About this trial
The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients. The main question it aims to answer is: Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing? Over a period of one month, one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session. Since we will conduct a monocentric, crossover randomized controlled trial, the participants act as their own control group.
Eligibility criteria
Qualifiers
Older than 18 years;
in treatment with thrice-weekly hemodialysis sessions;
regular hemodialysis duration of three to five hours
having no visual impairment
Disqualifiers
diagnosis of epilepsy
current pregnancy
Trial design
Treatments tested in this trial
- virtual reality therapy
Treatment groups
Locations
1Sponsors and collaborators
David Blum
Lead sponsor
University of Zurich
Sponsor institution